ABCC2 and neoplasm: In our analysis of a clinical gene expression dataset, we showed that ABCC2 was the only one of 18 oxaliplatin transporter candidate genes with differential tumour expression between CRC patients who did or did not respond to oxaliplatin-based chemotherapy [20].